Emetogenicity of Chemotherapies

Reference work entry


Chemotherapies can be classified according to their emetogenic potential in: highly emetogenic chemotherapies (almost all patients not receiving antiemetic prophylaxis suffer from CINV; i.e., cisplatin, dacarbazine); moderately emetogenic chemotherapies (many, but not all, patients suffer from CINV if not treated; i.e., cyclophosphamide- and anthracycline-containing chemotherapies); chemotherapies with a low emetogenic potential (only a very few patients who do not receive antiemetic prophylaxis experience CINV).


Public Health Social Policy Emetogenic Chemotherapy Antiemetic Prophylaxis Emetogenic Potential 

Copyright information

© Springer Science+Business Media LLC 2010

Personalised recommendations